Coronary computed tomography angiography and [(15)O]H(2)O positron emission tomography perfusion imaging for the assessment of coronary artery disease

Determining the anatomic severity and extent of coronary artery disease (CAD) by means of coronary computed tomography angiography (CCTA) and its effect on perfusion using myocardial perfusion imaging (MPI) form the pillars of the non-invasive imaging assessment of CAD. This review will 1) focus on...

Descripción completa

Detalles Bibliográficos
Autores principales: van Diemen, P. A., Schumacher, S. P., Driessen, R. S., Bom, M. J., Stuijfzand, W. J., Everaars, H., de Winter, R. W., Raijmakers, P. G., van Rossum, A. C., Hirsch, A., Danad, I., Knaapen, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419408/
https://www.ncbi.nlm.nih.gov/pubmed/32780333
http://dx.doi.org/10.1007/s12471-020-01445-7
Descripción
Sumario:Determining the anatomic severity and extent of coronary artery disease (CAD) by means of coronary computed tomography angiography (CCTA) and its effect on perfusion using myocardial perfusion imaging (MPI) form the pillars of the non-invasive imaging assessment of CAD. This review will 1) focus on CCTA and [(15)O]H(2)O positron emission tomography MPI as stand-alone imaging modalities and their combined use for detecting CAD, 2) highlight some of the lessons learned from the PACIFIC trial (Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve (FFR) (NCT01521468)), and 3) discuss the use of [(15)O]H(2)O PET MPI in the clinical work-up of patients with a chronic coronary total occlusion (CTO).

Ejemplares similares